ORAGENICS INC (OGEN) — Institutional Holders, Q2 2026

18 institutional investment managers reported a OGEN position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $39.2K. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.

OGEN in Q2 2026: what funds did

Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.

New positions

2

Added to

3

Trimmed

2

Sold out

6

Biggest buyers

  1. 25New · +23,160 sh+$13.6K
  2. JANE STREET GROUPNew · +12,771 sh+$7.5K
  3. St. Johns Investment Management CompanyAdded · +1,724 sh+$1.0K
  4. SBI Securities , Ltd.Added · +12 sh+$7.00

Biggest sellers

  1. PathstoneSold out · -55,001 sh-$32.4K
  2. GEODE CAPITAL MANAGEMENTTrimmed · -41,387 sh-$24.3K
  3. TWO SIGMA SECURITIESSold out · -20,343 sh-$12.0K
  4. HRT FINANCIALSold out · -18,672 sh-$11.0K
  5. Virtu FinancialSold out · -17,575 sh-$10.3K

OGEN 13F holders ranked 1–18 of 18

Institutional investors reporting a position in ORAGENICS INC on SEC Form 13F-HR for Q2 2026, ranked by reported value.
InstitutionValueQoQ
GEODE CAPITAL MANAGEMENT#1 · 23,685 sh$13.8K-63.6%
25#2 · 23,160 sh$13.4KNew
JANE STREET GROUP#3 · 12,771 sh$7.4KNew
Tower Research Capital (TRC)#4 · 4,548 sh$2.6K0.0%
St. Johns Investment Management Company#5 · 1,924 sh$1.1K+862.0%
BlackRock#6 · 703 sh$408.000.0%
UBS Group AG#7 · 642 sh$373.00-87.7%
WELLS FARGO & COMPANY#8 · 34 sh$20.000.0%
HARBOUR INVESTMENTS#9 · 34 sh$20.000.0%
SBI Securities , Ltd.#10 · 23 sh$13.00+109.1%
ADKINS SEALE CAPITAL MANAGEMENT#11 · 3 sh$2.000.0%
Johnson Financial Group#12 · 1 sh$1.000.0%
Bogart Wealth#13 · 1 sh$1.000.0%
Strategic Wealth Partners, Ltd.#14 · 1 sh$1.000.0%
Farther Finance Advisors#15 · 1 sh$1.000.0%
Keating Financial Advisory Services#16 · 1 sh$1.000.0%
ROYAL BANK OF CANADA#17 · 2 sh$0.00+100.0%
FMR#18 · 0 sh$0.00New

Funds that sold out of OGEN in Q2 2026 (6)

Held OGEN at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.

Institutions that held OGEN in Q1 2026 and reported no position in Q2 2026.
InstitutionValue in Q1 2026
Pathstone55,001 sh$30.8K
TWO SIGMA SECURITIES20,343 sh$11.4K
HRT FINANCIAL18,672 sh$10.0K
Virtu Financial17,575 sh$10.0K
Ameritas Advisory Services2,000 sh$1.1K
Western Wealth Management1,001 sh$561.00

Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.